checkAd

    IQE plc - macht Epiwafer - 500 Beiträge pro Seite

    eröffnet am 26.09.15 14:59:34 von
    neuester Beitrag 15.04.19 10:34:36 von
    Beiträge: 16
    ID: 1.219.149
    Aufrufe heute: 0
    Gesamt: 2.723
    Aktive User: 0

    IQE
    ISIN: GB0009619924 · WKN: 922677 · Symbol: IQE
    0,2815
     
    GBP
    -5,22 %
    -0,0155 GBP
    Letzter Kurs 19.04.24 London

    Werte aus der Branche Halbleiter

    WertpapierKursPerf. %
    4.005,00+300,50
    8,4500+16,55
    23,600+12,38
    33,95+11,09
    26,48+10,01
    WertpapierKursPerf. %
    81,80-17,04
    0,7050-18,50
    3,9900-20,20
    2,3000-23,08
    0,5530-38,56

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 26.09.15 14:59:34
      Beitrag Nr. 1 ()
      ...und bezeichnet sich als Marktführer; notiert am AIM.

      Bin über folgenden Technologiedeal drauf gestoßen:

      Licence and Option Agreement
      15 September 2015
      IQE signs an Exclusive Licence and Option Agreement to acquire Translucent Inc.’s Unique ‘cREO™’ Technology

      Cardiff, UK. 15 September 2015: IQE plc (AIM: IQE, “IQE” or the “Group”), the leading global supplier of advanced wafer products and wafer services to the semiconductor industry, announces that it has signed an agreement with Silex Systems Limited’s subsidiary, Translucent Inc. (“Translucent”), for the exclusive licence of Translucent’s unique and innovative ‘Rare Earth Oxide’ (cREO™) semiconductor technology, and taken an option to subsequently acquire the technology (the “Agreement”). Translucent’s cREO™ technology offers a unique approach to the manufacture of a wide range of innovative Compound Semonductor on Silicon products, including gallium nitride (GaN) on silicon (Si) for the burgeoning Power switching and RF technologies markets. It is protected by a wide ranging IP portfolio consisting of 74 granted patents, and 13 additional patent applications.

      Key terms of the Agreement:

      IQE has signed an exclusive Licence and Assignment Agreement with Silex Systems Limited’s (“Silex”, ASX: SLX) subsidiary Translucent Inc.
      The Agreement provides IQE with an exclusive 30 month licence for the commercialisation of the Translucent cREO™ technology and an exclusive option (exercisable solely at IQE’s discretion) on the subsequent acquisition of the cREO™ technology
      IQE will pay Silex up to a maximum consideration of USD 1.5 million1, payable within six months of the date of the Agreement in either cash or IQE shares2, for the the licence and option agreement
      The Agreement includes the transfer of a range of manufacturing and characterisation equipment from Translucent to IQE, and also includes the exclusive services of two key engineers for 12 months in order to transfer the cREO™ technology to IQE. Translucent will then cease all operations in Palo Alto, California, their sole development site
      Within the 30 month licence period, IQE has an exclusive option to acquire the cREO™ technology and IP portfolio for a consideration of USD 5 million, payable within 6 months following exercise of the option in either cash or IQE shares2. In addition, a long term royalty will be payable in cash to Translucent on the sale of IQE products which utilise the cREO™ technology transferred as follows: 3% on epi products, or 6% on cREO™ templates
      All new IP generated relating to the technology will belong exclusively to IQE, as of today’s date
      Should the licence expire after 30 months without IQE taking up the assignment option, or should the Agreement otherwise be terminated, all rights to the cREO™ technology that was transferred to IQE and the related equipment will revert to Translucent
      1 USD 0.085m of the maximum USD 1.5m consideration is conditional upon certain delivery obligations being met

      2 any share consideration would be calculated using a 5 day VWAP for the 5 trading days immediately preceding the applicable issue date

      IQE CEO Dr Drew Nelson said:

      “This is a first class deal and great opportunity for IQE. We are at the forefront of a new era in the semiconductor industry which is bringing to market unique high performance Compound Semiconductor materials required for the modern ‘Internet of Things’ world. At the same time we are leveraging the low cost and large wafer size benefits of the silicon industry that has been at the core of the information technology revolution over the last 40 years. We are very excited to be able to take Translucent’s unique ‘cREO™’ technology to market, and thereby create a significant new platform to drive our business into several new large volume areas”.
      Avatar
      schrieb am 26.09.15 15:06:14
      Beitrag Nr. 2 ()
      Avatar
      schrieb am 26.09.15 15:15:14
      Beitrag Nr. 3 ()
      Avatar
      schrieb am 30.09.15 15:22:00
      Beitrag Nr. 4 ()
      habe eine kleine Stückzahl erworben
      1 Antwort
      Avatar
      schrieb am 28.12.15 12:45:37
      Beitrag Nr. 5 ()
      von Edison:
      Growth in wireless sector slowing
      Weakness in the handset chip supply chain has broadened into Q4, most recently
      to include those with substantial exposure to Apple, such as Dialog and Imagination
      Technologies. However, the size of IQE’s market share (around 55% of the global
      outsourced wireless epitaxy market) reduces its exposure to any individual phone
      manufacturer even though customer consolidation makes some ‘lumpiness’ in
      revenues inevitable. Moreover, while market growth is flattening, we believe that
      the sector should remain an important cash cow for IQE.

      Diversification activity accelerating
      The photonics business continues to perform strongly, delivering significant double-­
      digit revenue growth. A mix of applications contributed to this growth, particularly
      data centre connectivity, optical communications and a broad range of sensor
      products. The InfraRed and CMOS++ businesses also performed well. The first
      pilot production revenues were generated from Solar-­related activities for ultimate
      deployment in the Middle East. Significantly, during FY15 IQE formed joint ventures
      in Singapore and the UK heralding the start of IP licensing. This additional revenue
      stream is likely to become more significant longer term if IQE’s technology is
      deployed in volume applications such as general-­purpose LED lighting and solar
      power. We leave our estimates unchanged, noting that weakness in the wireless
      sector may persist into 2016.

      Valuation: Undemanding rating
      The reported weakness in the wireless market has weighed down on the share
      price, which has fallen by 32% since October. IQE’s rating is undemanding and
      remains at a substantial discount to its peers. If the business progresses to plan,
      we should see its revenues continue to diversify, cash conversion improve as the
      RFMD wafer discount tapers off and the balance sheet strengthen as the final
      tranche of deferred consideration for Kopin is paid. We believe these factors should
      be a catalyst for an upward re-­rating of the shares.

      Trading Spotlight

      Anzeige
      Nurexone Biologic
      0,4300EUR +4,62 %
      Voller Fokus auf NurExone Biologic!mehr zur Aktie »
      Avatar
      schrieb am 15.09.16 11:30:43
      Beitrag Nr. 6 ()
      Antwort auf Beitrag Nr.: 50.743.542 von R-BgO am 30.09.15 15:22:00
      aufgestockt;
      finde das klingt nicht schlecht:

      13 September 2016

      Accelerating growth in photonics helps deliver strong uplift in profit and cash generation



      Cardiff, UK. 13 September 2016: IQE plc (AIM: IQE, “IQE” or the “Group”), the leading global supplier of advanced wafer products and wafer services to the semiconductor industry, announces its unaudited half year results for the six months to 30 June 2016.

      FINANCIAL HIGHLIGHTS

      -Strong financial performance with double digit growth in revenues, profits and cash generation
      -Revenues up 18% reflecting increasing revenues in all markets
      -Adjusted fully diluted EPS up 62% with the benefit of the Groups highly geared business model
      -Increased profitability converted into 176% increase in cash generated from operations
      -Balance sheet leverage reduced by 28% to £35.4m
      -Kopin deferred consideration balance of £10.7m settled in full in January 2016
      -Remaining balance of deferred consideration will be settled in full by the end of this month (September 16).


      OPERATIONAL HIGHLIGHTS

      -Continuing diversification of revenues with non-wireless revenues accounting for 31% of sales (H1 2015: 24%)
      -Accelerating photonics growth, with sales up 45% year on year
      -Wireless performing well with sales up 7%
      -Robust performance in Infrared and CMOS++ with sales up in both segments
      -License income of £3.5m from joint ventures, which continue to perform well
      -Strong progress with new product qualifications underpin the pipeline for continuing growth
      -Continuing to strengthen technology leadership and IP portfolio


      Dr Drew Nelson, IQE Chief Executive, said:

      “IQE’s continued strong financial performance reflects the significant progress made in diversifying revenues over the past few years, and its growing portfolio of intellectual property. A healthy performance in Wireless and IR has been supplemented by accelerated growth in photonics which is up 45%. The photonics market is being driven by a diverse range of applications, and is at an early stage in the growth cycle. We expect our photonics business to continue to grow strongly for the foreseeable future.

      IQE has developed a broad portfolio of intellectual property for advance semiconductor materials. In addition to the £3.5m of license income generated in the first half, this IP portfolio is increasingly enabling IQE to differentiate itself, and create a platform for continuing growth across its current and emerging markets.IQE has a pipeline of new products and customer qualifications which underpin its growth ambitions, with programs expected to ramp through 2017 and 2018. This includes new photonic applications, wireless base stations, advanced solar, and power switching applications.”
      Avatar
      schrieb am 02.12.16 09:29:40
      Beitrag Nr. 7 ()
      BLUGLASS AND IQE ENTER INTO A STRATEGIC PARTNERSHIP TO DEVELOP A RANGE OF ELECTRONIC APPLICATIONS
      November 28, 2016


      Key Points

      * BluGlass and IQE have entered into an Exclusive Collaboration Agreement to co-develop nitride films for a range of electronic devices on both silicon and IQE's cREO™ technology using BluGlass’ unique low temperature RPCVD technology

      * IQE is the leading foundry manufacturer of advanced semiconductor wafer products to the global semiconductor industry


      Australian technology innovator BluGlass Limited (ASX:BLG) has today announced that it has entered into a formal Collaboration Agreement with IQE (AIM: IQE), a global leader in the design and manufacture of advanced semiconductor wafer products.

      IQE products are used by major global chip companies to produce the high performance components that enable a wide range of high-tech applications including for the wireless industry, such as smartphone and wireless infrastructure, Wi-Fi, base stations, GPS, and satellite communications; optical communications and optical storage.

      The two companies will work together to develop specific enabling technology for high quality nitride films deposited by Remote Plasma Chemical Vapour Deposition (RPCVD) on both silicon wafers and on specially engineered substrates; cREO™ on silicon.

      IQE Group’s Vice President, Dr. Rodney Pelzel said today “We are extremely pleased to announce our collaboration with BluGlass. BluGlass’ world leading RPCVD technology is highly complementary to IQE’s existing technology portfolio, and the collaboration is a key step in overcoming challenges inherent to epi-growth of cutting edge materials”.

      “This arrangement marks another key milestone for IQE as it continues to provide market leading solutions to its customers. This arrangement comes on the heels of our announcement earlier this year of successful transfer of cREO™ epi capability to IQE’s North Carolina manufacturing site. This collaborative arrangement is a key step in furthering this technology.” Dr. Pelzel added.

      BluGlass Managing Director, Giles Bourne said today “We are delighted to have formed a strategic partnership with IQE, one of the world’s leading compound semiconductor foundries, supplying many of today’s leading semiconductor manufacturers”. Mr. Bourne added “We have chosen to work with IQE, based on the enormous market potential and impact that the applications that we will be co-developing could have on the semiconductor industry in the future. IQE is committed to cutting-edge innovation and their diverse product portfolio makes them a very compelling partner to be working with”.
      Avatar
      schrieb am 30.03.17 13:10:27
      Beitrag Nr. 8 ()
      weiter aufgestockt
      2 Antworten
      Avatar
      schrieb am 04.10.17 11:14:34
      Beitrag Nr. 9 ()
      Antwort auf Beitrag Nr.: 54.643.553 von R-BgO am 30.03.17 13:10:27
      nach fettem run-up
      erstmal raus bis aufs Erinnerungsstück;

      verstehe zu wenig von dem Thema
      1 Antwort
      Avatar
      schrieb am 01.12.17 11:22:33
      Beitrag Nr. 10 ()
      Lumentum to buy VCSEL epitaxial wafers from Epistar, says paper

      Adam Hwang, DIGITIMES, Taipei [Friday 1 December 2017]

      US-based Lumentum, a supplier of VCSEL (vertical-cavity surface-emitting laser) diodes used in 3D sensors for iPhone X, is seeking to purchase VCSEL epitaxial wafers from Taiwan-based LED wafer and chip maker Epistar, according to a Chinese-language Economic Daily News (EDN) report.

      Lumentum usually purchases VCSEL wafers from UK-based IQE. However, the supply of such products from IQE is not sufficient to meet Lumentum's demand, said the report.

      In response to potential orders from Lumentum, Epistar reportedly plans to relocate 5-10 sets of its MOCVD equipment used in the production of 4-inch LED wafers for production of 6-inch VCSEL wafers, added the report.
      Avatar
      schrieb am 17.05.18 11:42:26
      Beitrag Nr. 11 ()
      Antwort auf Beitrag Nr.: 55.876.468 von R-BgO am 04.10.17 11:14:34
      Muddy Waters hat sie auf dem Kieker:
      http://d.muddywatersresearch.com/company/iqe/
      Avatar
      schrieb am 08.11.18 06:45:56
      Beitrag Nr. 12 ()
      Edison Research aus 2017
      https://www.edisoninvestmentresearch.com/?ACT=18&ID=19560&LA…

      (beobachten, scheint mir etwas hochgelaufen wegen Apple-Fantasien...)
      Avatar
      schrieb am 23.01.19 10:55:39
      Beitrag Nr. 13 ()
      das hier war wohl der Knick im November:
      12 November 2018

      IQE plc issues this trading update in response to reports made by a major chip company in the VCSEL supply chain on 12th November 2018 that they had received notice from one of their largest customers for 3D sensing laser diodes to materially reduce shipments for the current quarter.

      The Company is currently assessing the impact of this news but at this stage, it expects there will be a material reduction in its financial performance in the current year.
      3 Antworten
      Avatar
      schrieb am 23.01.19 10:59:20
      Beitrag Nr. 14 ()
      Antwort auf Beitrag Nr.: 59.691.537 von R-BgO am 23.01.19 10:55:39
      nach einem Tag Nachdenken kam dann das:
      Cardiff, UK. 13th November 2018

      IQE plc (AIM: IQE; "IQE", the “Company” or the "Group"), the leading global supplier of advanced wafer products and materials solutions to the semiconductor industry, provides the following trading update further to the announcement made by IQE on 12th November 2018.

      IQE confirms it was notified on 12th November 2018, following an announcement made by a major chip company in the VCSEL supply chain on the same day, that the chip company had received notice from one of their largest customers for 3D sensing laser diodes that they would materially reduce shipments for the current quarter.

      As a consequence of the change in market conditions, IQE announces that it now expects to deliver revenues of approximately £160m for FY 2018 (H1 2018 £73.4m, FY 2017 £154.6m).

      Photonics demand was facing a later but steeper Photonics ramp for VCSELs for consumer products moving into Q4 2018, a reflection of the 6 inch VCSEL inventory overbuild in FY 2017 being larger and taking longer than expected to be consumed during FY 2018.

      With the impact of this recent announcement coming at this critical time, Photonics wafer revenues growth for FY 2018, on a constant currency basis, is now expected to be approximately 11% (previous guidance for FY 2018 Photonics wafer revenue: 35% to 50%) and based on early initial indications, is currently expected to return to previously guided levels of 40% to 60% revenue growth in FY 2019.

      Wireless wafer revenues for FY 2018, on a constant currency basis, is expected to grow at 8%, above the top end of the 0% to 5% revenue growth guidance, given in the Company’s H1 trading statement.

      Wireless demand, especially for GaN products, has been strong and capacity was retained through Q3 2018, to continue to address demand following the replenishment of inventory channels depleted during H2 2017. The late ramp of Photonics production also provided an extended opportunity for additional engagement and qualification programs with more than 25 VCSEL chip manufacturers.

      Infrared wafer revenues, on a constant currency basis, is also expected to grow at or exceed the top end of current CAGR guidance range of 5% to 15% for FY 2018 and remain in the 5% to 15% range for FY 2019.

      As a result, FY 2018 Adjusted EBITDA is now expected to be approximately £31m (FY 2017 £37.1m).
      2 Antworten
      Avatar
      schrieb am 23.01.19 12:26:08
      Beitrag Nr. 15 ()
      Antwort auf Beitrag Nr.: 59.691.579 von R-BgO am 23.01.19 10:59:20
      Es juckt mich ja, wieder einzusteigen,
      aber gleichzeitig habe ich Bauchgrummeln:

      -war zu faul, die Short-Attacken im Detail nachzuvollziehen, aber irgendwas scheint doch dran zu sein
      -operativ scheint es sie zu geben ,aber billig sind sie immer noch nicht
      -sie haben den Restkaufpreis für Crew im September mit Aktien bezahlt, als die noch bei rund 100 pence standen, offenbar hielten sie das für weniger wert als 5 MUSD in cash
      -die KE Ende 2017 war sicher gut "getimt" - in jeder Hinsicht

      => denke, es macht Sinn erstmal bis zum 20.3. abzuwarten, und den GB anzuschauen
      1 Antwort
      Avatar
      schrieb am 15.04.19 10:34:36
      Beitrag Nr. 16 ()
      Antwort auf Beitrag Nr.: 59.692.311 von R-BgO am 23.01.19 12:26:08
      Gewinn hat sich
      fast vollständig in Luft aufgelöst;

      weiter Seitenlinie


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.

      Investoren beobachten auch:

      WertpapierPerf. %
      -0,82
      +0,08
      -3,03
      IQE plc - macht Epiwafer